Back to search
FDAFDA · Food and drugs·Recall number D-0597-2018

Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Hospira, Inc., Lake forest, IL 60045 USA. NDC: 0409-2634-01

Published March 21, 2018 · Recall initiated: February 7, 2018

Summary

FDA records drug Class I recall D-0597-2018, published March 21, 2018 and initiated February 7, 2018. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 29, 680 vials; Lot: Lot 71330DD EXP. 11/1/2018. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.

What to do

Voluntary: Firm initiated · Letter

Get an email if HYDROMORPHONE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
HYDROMORPHONE HYDROCHLORIDE
Manufacturer
Pfizer Inc.
Distributor
Nationwide in the USA
Lot
Lot 71330DD EXP. 11/1/2018.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Hospira, Inc., Lake forest, IL 60045 USA. NDC: 0409-2634-01 recalled?

Yes. FDA published recall D-0597-2018 on March 21, 2018. Reported hazard: Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: HYDROMORPHONE HYDROCHLORIDE.